197 related articles for article (PubMed ID: 10886211)
21. [GPI-PLD gene exon14 polymorphisms of leucocyte in peripheral blood from healthy persons and leukemia patients].
Yang ZY; Huang H; Tang JH; Yu H; Wang YD; Xiang XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):28-31. PubMed ID: 16562670
[TBL] [Abstract][Full Text] [Related]
22. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia.
Jaroslav P; Martina H; Jirí S; Hana K; Petr S; Tomás K; Julius M; Cedrik H
Leuk Lymphoma; 2005 Nov; 46(11):1605-1612. PubMed ID: 16334487
[TBL] [Abstract][Full Text] [Related]
23. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.
Willis TG; Jadayel DM; Du MQ; Peng H; Perry AR; Abdul-Rauf M; Price H; Karran L; Majekodunmi O; Wlodarska I; Pan L; Crook T; Hamoudi R; Isaacson PG; Dyer MJ
Cell; 1999 Jan; 96(1):35-45. PubMed ID: 9989495
[TBL] [Abstract][Full Text] [Related]
24. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
Melo JV; Goldman JM
Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
[TBL] [Abstract][Full Text] [Related]
25. Lack of mutations of BCL6 and BCL10 genes in mucosa-associated lymphoid tissue lymphomas of the orbital adnexa.
Chen PM; Liu JH; Yu IT; Kao SC; Lin YC; Chiang H; Fan FS; Chiou TJ; Wang WS; Yen CC
Cancer Genet Cytogenet; 2000 Nov; 123(1):44-8. PubMed ID: 11120333
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.
Rozenfeld-Granot G; Toren A; Amariglio N; Brok-Simoni F; Rechavi G
Exp Hematol; 2001 Feb; 29(2):228-33. PubMed ID: 11166462
[TBL] [Abstract][Full Text] [Related]
27. Rearrangement of immunoglobulin and T cell receptor genes in acute and chronic leukaemias.
Liang R; Chan VV; Chan TK; Chiu E; Todd D
Acta Haematol; 1991; 85(2):71-5. PubMed ID: 1850943
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
29. Absence of post-transcriptional RNA modifications of BCL10 in human malignant mesothelioma and colorectal cancer.
Apostolou S; Murthy SS; Kolachana P; Jhanwar SC; Testa JR
Genes Chromosomes Cancer; 2001 Jan; 30(1):96-8. PubMed ID: 11107182
[TBL] [Abstract][Full Text] [Related]
30. Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia.
Langabeer SE; Quinn F; O'Brien D; McElligott AM; Kelly J; Browne PV; Vandenberghe E
Leuk Res; 2012 Apr; 36(4):483-4. PubMed ID: 22230299
[TBL] [Abstract][Full Text] [Related]
31. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
32. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
34. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
[TBL] [Abstract][Full Text] [Related]
35. Decreased or altered expression of the FHIT gene in human leukemias.
Sugimoto K; Yamada K; Miyagawa K; Hirai H; Oshimi K
Stem Cells; 1997; 15(3):223-8. PubMed ID: 9170214
[TBL] [Abstract][Full Text] [Related]
36. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
37. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).
Zhang Q; Siebert R; Yan M; Hinzmann B; Cui X; Xue L; Rakestraw KM; Naeve CW; Beckmann G; Weisenburger DD; Sanger WG; Nowotny H; Vesely M; Callet-Bauchu E; Salles G; Dixit VM; Rosenthal A; Schlegelberger B; Morris SW
Nat Genet; 1999 May; 22(1):63-8. PubMed ID: 10319863
[TBL] [Abstract][Full Text] [Related]
38. Pattern of FHIT gene expression in normal and leukaemic cells.
Yang HW; Piao HY; Taki T; Chen T; Hashizume K; Ohnishi H; Bessho F; Yanagisawa M; Matsuo Y; Hayashi Y
Int J Cancer; 1999 Jun; 81(6):897-901. PubMed ID: 10362136
[TBL] [Abstract][Full Text] [Related]
39. Lack of Bcl10 mutations in malignant cartilaginous tumors.
Park YK; Park HR; Kim YW; Chi SG; Unni KK
Int J Mol Med; 2002 Mar; 9(3):217-9. PubMed ID: 11836626
[TBL] [Abstract][Full Text] [Related]
40. High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia.
Burger H; Nooter K; Sonneveld P; Van Wingerden KE; Zaman GJ; Stoter G
Br J Haematol; 1994 Oct; 88(2):348-56. PubMed ID: 7803281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]